Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammation01:38

Inflammation

51.7K
Overview
51.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

8.4K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

4.9K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
4.9K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

46.0K
Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
46.0K
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

6.6K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep and repetitive transcranial magnetic stimulation improves motor dysfunction after basal ganglia infarction: preliminary findings on efficacy and electrophysiological mechanisms.

Frontiers in neuroscience·2026
Same author

Endomorphin analogs CEMR-1 and CEMR-2 administered intravenously display potent antinociception with limited tolerance in acute, neuropathic and inflammatory pain.

Neuropharmacology·2026
Same author

Psychosocial etiology and management of chronic pelvic pain in women: a systematic review.

BMC psychology·2026
Same author

Humic acid and tryptophan prolong virus survival and infectivity: Molecular interactions and mechanisms.

Water research·2026
Same author

Caged xanthones with cytotoxic activity from the leaves and twigs of Garcinia oligantha.

Phytochemistry·2026
Same author

Spatiotemporal analysis of climatic and anthropogenic drivers of winter smog in the Indo-Gangetic Plain with a focus on Lahore.

Environmental science and pollution research international·2026

Related Experiment Video

Updated: May 14, 2025

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

20.1K

The cGAS-STING pathway in atherosclerosis.

Si-Yu Wang1,2,3, Yu-Shan Chen1,2, Bo-Yuan Jin1,2,3

  • 1Heart Center/National Regional (Traditional Chinese Medicine) Cardiovascular Diagnosis and Treatment Center, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.

Frontiers in Cardiovascular Medicine
|May 12, 2025
PubMed
Summary

The cGAS-STING pathway drives atherosclerosis (AS) by promoting inflammation. Inhibiting this pathway offers a promising strategy to treat cardiovascular diseases (CVD).

Keywords:
STING inhibitorsatherosclerosiscGAS inhibitorscGAS-STING pathwayrisk factorstherapeutic potential

More Related Videos

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli
07:26

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Published on: December 26, 2020

3.9K
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

17.5K

Related Experiment Videos

Last Updated: May 14, 2025

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

20.1K
Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli
07:26

Site Specific Lysine Acetylation of Histones for Nucleosome Reconstitution using Genetic Code Expansion in Escherichia coli

Published on: December 26, 2020

3.9K
A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites
09:52

A Mouse Model for Pathogen-induced Chronic Inflammation at Local and Systemic Sites

Published on: August 8, 2014

17.5K

Area of Science:

  • Immunology
  • Cardiovascular Science
  • Molecular Biology

Background:

  • Atherosclerosis (AS) is a chronic inflammatory disease and a major cause of cardiovascular morbidity and mortality.
  • The cGAS-STING pathway, an innate immune signaling cascade, is increasingly recognized for its role in AS progression.
  • Risk factors for AS may amplify the cGAS-STING pathway, exacerbating inflammation.

Purpose of the Study:

  • To review the mechanisms of the cGAS-STING pathway.
  • To explore the role of the cGAS-STING pathway in atherosclerosis.
  • To evaluate potential therapeutic inhibitors targeting the cGAS-STING pathway for cardiovascular diseases (CVD).

Main Methods:

  • Literature review of studies on the cGAS-STING pathway and atherosclerosis.
  • Analysis of the molecular mechanisms underlying cGAS-STING pathway activation in AS.
  • Evaluation of preclinical and clinical data on cGAS-STING inhibitors.

Main Results:

  • The cGAS-STING pathway is activated by cytoplasmic DNA, leading to inflammation and plaque formation in AS.
  • Established AS risk factors may potentiate cGAS-STING signaling, amplifying inflammatory responses.
  • Several inhibitors targeting the cGAS-STING pathway show therapeutic potential.

Conclusions:

  • The cGAS-STING pathway is a critical mediator of inflammation in atherosclerosis.
  • Targeting the cGAS-STING pathway presents a novel therapeutic avenue for AS and associated CVD.
  • Further research into cGAS-STING inhibitors could lead to effective treatments for cardiovascular diseases.